We apply cutting-edge machine learning to the vast, untapped potential of natural products to identify and develop next-generation therapeutics.
We curate and analyze diverse bioactive molecules, focusing on enzyme inhibitors with proven biological interactions.
AI algorithms analyze complex biological data to predict molecular behavior and therapeutic potential.
We have identified new compounds with high efficacy, enabling faster and more targeted drug discovery.
Our algorithm has successfully identified antibacterial compounds that reverse antibiotic resistance, both Gram positive and Gram negative deadly pathogens a critical step forward in the fight against Multi-Drug Resistant (MDR) and Extensively Drug Resistant (XDR) bacteria.
New Compounds Identified
That Reverse Antibiotic Resistance
